Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiation

Journal of Immunology

Volumn 176, Issue 9, 2006, Pages 5191-5198

  Van De Ven, Rieneke ^a   De Jong, Mariska C ^a   Reurs, Anneke W ^a   Schoonderwoerd, Antoinet J N ^a   Jansen, Gerrit ^a   Hooijberg, Jan H ^a   Scheffer, George L ^a   De Gruijl, Tanja D ^a   Scheper, Rik J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CD1 ANTIGEN; CD14 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR; GANGLIOSIDE GM1; GLYCOPROTEIN P; HLA DR ANTIGEN; LEUKOTRIENE C4; MONOSIALOGANGLIOSIDE; MULTIDRUG RESISTANCE PROTEIN 1; T6 ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MEMBRANE TRANSPORT; CELL MIGRATION; DENDRITIC CELL; EFFECTOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LANGERHANS CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 33645977500     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.9.5191     Document Type: Article

References (43)

1. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
2. Whiteside, T. L., and C. Odoux. 2004. Dendritic cell biology and cancer therapy. Cancer Immunol. Immunother. 53: 240-248.
3. Borst, P., R. Evers, M. Kool, and J. Wijnholds. 2000. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92: 1295-1302.
4. Borst, P., N. Zelcer, and A. van Helvoort. 2000. ABC transporters in lipid transport. Biochim. Biophys. Acta 1486: 128-144.
5. Heemels, M. T., T. N. Schumacher, K. Wonigeit, and H. L. Ploegh. 1993. Peptide translocation by variants of the transporter associated with antigen processing. Science 262: 2059-2063.
6. Juliano, R. L., and V. Ling. 1976. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455: 152-162.
7. Cole, S. P., G. Bhardwaj, J. H. Gerlach, J. E. Mackie, C. E. Grant, K. C. Almquist, A. J. Stewart, E. U. Kurz, A. M. Duncan, and R. G. Deeley. 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654.
8. Gottesman, M. M., T. Fojo, and S. E. Bates. 2002. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2: 48-58.
9. Schinkel, A. H., and J. W. Jonker. 2003. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55: 3-29.
10. Randolph, G. J., S. Beaulieu, M. Pope, I. Sugawara, L. Hoffman, R. M. Steinman, and W. A. Muller. 1998. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc. Natl. Acad. Sci. USA 95: 6924-6929.
11. 4 transporter MRP1 regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103: 757-768.
12. Leier, I., G. Jedlitschky, U. Buchholz, S. P. Cole, R. G. Deeley, and D. Keppler. 1994. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 269: 27807-27810.
13. Randolph, G. J. 2001. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin. Immunol. 13: 267-274.
14. Raggers, R. J., I. Vogels, and G. van Meer. 2001. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. Biochem. J. 357: 859-865.
15. Honig, S. M., S. Fu, X. Mao, A. Yopp, M. D. Gunn, G. J. Randolph, and J. S. Bromberg. 2003. FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes. J. Clin. Invest. 111: 627-637.
16. Baas, F., A. P. Jongsma, H. J. Broxterman, R. J. Arceci, D. Housman, G. L. Scheffer, A. Riethorst, M. van Groenigen, A. W. Nieuwint, and H. Joenje. 1990. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Cancer Res. 50: 5392-5398.
17. Zijlstra, J. G., E. G. de Vries, and N. H. Mulder. 1987. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res. 47: 1780-1784.
18. Kuiper, C. M., H. J. Broxterman, F. Baas, G. J. Schuurhuis, H. J. Haisma, G. L. Scheffer, J. Lankelma, and H. M. Pinedo. 1990. Drug transport variants without P-glycoprotein overexpression from a human squamous lung cancer cell line after selection with doxorubicin. J. Cell Pharmacol. 1: 35-41.
19. Chapuis, F., M. Rosenzwajg, M. Yagello, M. Ekman, P. Biberfeld, and J. C. Gluckman. 1997. Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. 27: 431-441.
20. Schroeijers, A. B., A. W. Reurs, G. L. Scheffer, A. G. Stam, M. C. de Jong, T. Rustemeyer, E. A. Wiemer, T. D. de Gruijl, and R. J. Scheper. 2002. Upregulation of drug resistance-related vaults during dendritic cell development. J. Immunol. 168: 1572-1578.
21. Salerno, M., P. Loechariyakul, C. Saengkhae, and A. Garnier-Suillerot. 2004. Relation between the ability of some compounds to modulate the MRP1-mediated efflux of glutathione and to inhibit the MRP1-mediated efflux of daunorubicin. Biochem. Pharmacol. 68: 2159-2165.
22. Courtois, A., L. Payen, D. Lagadic, A. Guillouzo, and O. Fardel. 1999. Evidence for a multidrug resistance-associated protein 1 (MRP1)-related transport system in cultured rat liver biliary epithelial cells. Life Sci. 64: 763-774.
23. Smith, A. J., U. Mayer, A. H. Schinkel, and P. Borst. 1998. Availability of PSC833, a substrate and inhibitor of P-glycoproteins, in various concentrations of serum. J. Natl. Cancer Inst. 90: 1161-1166.
24. + precursors. Blood 100: 701-703.
25. Manolova, V., Y. Hirabayashi, L. Mori, and G. De Libero. 2003. CD1a and CD1b surface expression is independent from de novo synthesized glycosphingolipids. Eur. J. Immunol. 33: 29-37.
26. Scheper, R. J., J. W. Bulte, J. G. Brakkee, J. J. Quak, E. van der Schoot, A. J. Balm, C. J. Meijer, H. J. Broxterman, C. M. Kuiper, J. Lankelma, and H. M. Pinedo. 1988. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance. Int. J. Cancer 42: 389-394.
27. Flens, M. J., M. A. Izquierdo, G. L. Scheffer, J. M. Fritz, C. J. Meijer, R. J. Scheper, and G. J. Zaman. 1994. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res. 54: 4557-4563.
28. Reinherz, E. L., P. C. Kung, G. Goldstein, R. H. Levey, and S. F. Schlossman. 1980. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc. Natl. Acad. Sci. USA 77: 1588-1592.
29. van der Pol, M. A., J. M. Pater, N. Feller, A. H. Westra, A. van Stijn, G. J. Ossenkoppele, H. J. Broxterman, and G. J. Schuurhuis. 2001. Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemia. Leukemia 15: 1554-1563.
30. Sombroek, C. C., A. G. Stam, A. J. Masterson, S. M. Lougheed, M. J. Schäkel, C. J. Meijer, H. M. Pinedo, A. J. van den Eertwegh, R. J. Scheper, and T. D. de Gruijl. 2002. Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J. Immunol. 168: 4333-4343.
31. 2 is a selective inducerof interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 97: 3466-3469.
32. Garrigos, M., J. Belehradek, Jr., L. M. Mir, and S. Orlowski. 1993. Absence of cooperativity for MgATP and verapamil effects on the ATPase activity of P-glycoprotein containing membrane vesicles. Biochem. Biophys. Res. Commun. 196: 1034-1041.
33. Klokouzas, A., C. P. Wu, H. W. van Veen, M. A. Barrand, and S. B. Hladky. 2003. cGMP and glutathione-conjugate transport in human erythrocytes. Eur. J. Biochem. 270: 3696-3708.
34. Heijn, M., R. P. Oude Elferink, and P. L. Jansen. 1992. ATP-dependent multi-specific organic anion transport system in rat erythrocyte membrane vesicles. Am. J. Physiol. 262: C104-C110.
35. Laupeze, B., L. Amiot, N. Bertho, J. M. Grosset, G. Lehne, R. Fauchet, and O. Fardel. 2001. Differential expression of the efflux pumps P-glycoprotein and multidrug resistance-associated protein in human monocyte-derived dendritic cells. Hum. Immunol. 62: 1073-1080.
36. Monaco, J. J. 1992. Major histocompatibility complex-linked transport proteins and antigen processing. Immunol. Res. 11:125-132.
37. Heemels, M. T., and H. Ploegh. 1995. Generation, translocation, and presentation of MHC class 1-restricted peptides. Annu. Rev. Biochem. 64: 463-491.
38. Shamshiev, A., H. J. Gober, A. Donda, Z. Mazorra, L. Mori, and G. De Libero. 2002. Presentation of the same glycolipid by different CD1 molecules. J. Exp. Med. 195: 1013-1021.
39. Merrill, A. H., Jr., E. Wang, T. R. Vales, E. R. Smith, J. J. Schroeder, D. S. Menaldino, C. Alexander, H. M. Crane, J. Xia, D. C. Liotta, et al. 1996. Fumonisin toxicity and sphingolipid biosynthesis. Adv. Exp. Med. Biol. 392: 297-306.
40. + hematopoietic progenitors and in lymphoid organs. Blood 96: 3857-3865.
41. Pesheva, P., S. Gloor, M. Schachner, and R. Probstmeier. 1997. Tenascin-R is an intrinsic autocrine factor for oligodendrocyte differentiation and promotes cell adhesion by a sulfatide-mediated mechanism. J. Neurosci. 17: 4642-4651.
42. Hara, A., K. Uemura, and T. Taketomi. 1996. Sulfatide prolongs blood-coagulation time and bleeding time by forming a complex with fibrinogen. Glycoconj. J. 13: 187-194.
43. Roberts, D. D., U. M. Wewer, L. A. Liotta, and V. Ginsburg. 1988. Laminin-dependent and laminin-independent adhesion of human melanoma cells to sulfatides. Cancer Res. 48: 3367-3373.